featured
Relatlimab-Nivolumab Ups PFS in Untreated Advanced Melanoma
Combination provides greater benefit than nivolumab alone for progression-free survival in untreated metastatic or unresectable melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.